Precision Biosciences Inc (NASDAQ:DTIL) price on Thursday, March 28, rose 4.47% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $13.56.
A look at the stock’s price movement, the close in the last trading session was $12.98. Turning to its 52-week performance, $28.44 and $8.25 were the 52-week high and 52-week low respectively. Overall, DTIL moved -26.94% over the past month.
Precision Biosciences Inc’s market cap currently stands at around $55.05 million, with investors looking forward to this quarter’s earnings report slated for May 07, 2024 – May 13, 2024. Analysts project the company’s earnings per share (EPS) to be -$2.11, which has seen fiscal year 2024 EPS growth forecast to increase to -$8.74 and about -$6.96 for fiscal year 2025. Per the data, EPS growth is expected to be 45.20% for 2024 and 20.40% for the next financial year.
Analysts have a consensus estimate of $7.47 million for the company’s revenue for the quarter, with a low and high estimate of $3.1 million and $10.5 million respectively. Wall Street analysts have also projected the company’s year-on-year revenue for 2024 to grow to $31.42 million, representing a -35.50% decline on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that DTIL is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
DTIL’s current price about 9.57% and 10.89% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.90, while 7-day volatility ratio is 7.92% and 7.49% in the 30-day chart. Further, Precision Biosciences Inc (DTIL) has a beta value of 1.52, and an average true range (ATR) of 1.01.
If we refocus on Precision Biosciences Inc (NASDAQ:DTIL), historical trading data shows that trading volumes averaged 0.14 million over the past 10 days and 127.55K over the past 3 months. The company’s latest data on shares outstanding shows there are 4.16 million shares.
The 11.50% of Precision Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 65.60% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.18 million on Mar 15, 2024, giving us a short ratio of 0.88. The data shows that as of Mar 15, 2024 short interest in Precision Biosciences Inc (DTIL) stood at 2.71% of shares outstanding, with shares short rising to 39790.0 registered in Feb 15, 2024. Current price change has pushed the stock 23.84% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DTIL stock continues to rise going into the next quarter.
